Related Experiment Videos
Ovarian cancer management. Practice guidelines for nuclear physicians
J M Classe1, R Fontanelli, A Bischof-Delaloye
1Surgical Department, Centre René Gauducheau, Nantes Saint Herblain, France. im-classe@nantes.fnclcc.fr
Summary
Advanced ovarian cancer frequently recurs despite initial treatment. This review covers diagnosis, prognosis, and treatment strategies, including nuclear medicine imaging for better patient outcomes.
Area of Science:
- Oncology
- Medical Imaging
Background:
- Ovarian cancer is a severe malignancy, with over 75% diagnosed at advanced stages.
- Despite initial treatment response rates of 70-80%, advanced ovarian cancer has poor long-term survival (20-30% at 5 years).
- Most patients experience relapse with metastatic, unresectable, or drug-resistant disease.
Purpose of the Study:
- To review current knowledge on ovarian cancer diagnosis, prognostic factors, and treatments.
- To discuss both conventional and nuclear medicine diagnostic procedures for ovarian cancer.
Main Methods:
- Literature review of diagnostic and treatment strategies for advanced ovarian cancer.
- Focus on non-nuclear medicine and nuclear medicine imaging techniques.
Main Results:
- Advanced ovarian cancer diagnosis often occurs late, complicating treatment.
- Relapse is common, characterized by peritoneal spread and resistance to therapies.
- Nuclear medicine offers advanced diagnostic capabilities for staging and monitoring.
Conclusions:
- Improved diagnostic approaches, including nuclear medicine, are crucial for managing advanced ovarian cancer.
- Understanding prognostic factors and treatment options is vital for improving patient survival.
- Further research into novel therapies and integrated diagnostic strategies is warranted.